Dec 2 2012Dr Marijn Dekkers, chairman of the management group of German pharmaceuticals group Bayer discusses eurozone certainty, pressure on drugs prices, problems in India with patents and opposition to genetically-modified food. He was interviewed by the FT's Andrew Jack.(5m 1sec)